Andarix Pharmaceuticals

Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond. Its lead product Tozaride targets specific cancers at the molecular level, and its companion diagnostic identifies the patients with the corresponding molecular signature who are the best candidates for therapy.